*Special treat Jingfeng (000908.SZ) announcement, the company's wholly-owned subsidiary Shanghai Jingfeng Pharmaceutical Co., Ltd. (referred to as "shanghai Jingfeng")...
According to the Zhitong Finance APP, *Special treat Jingfeng (000908.SZ) announced that its wholly-owned subsidiary, Shanghai Jingfeng Pharmaceutical Co., Ltd. (referred to as "shanghai Jingfeng"), intends to sell 567 units of properties known as "Taihu Zhixing" in Wu Zhong District, Suzhou Taihu National Tourist Resort in Suzhou to Changde Changshixingde Consulting Management Partnership Enterprise (Limited Partnership) (referred to as "Changshixingde") at a price of 64.6928 million yuan. The company plans to sign an "Asset Sale Agreement" with Changshixingde.
It is reported that this trade will help the company revitalize existing assets, reduce the scale of liabilities, further optimize the company's asset-liability structure, and alleviate debt pressure.
